Synthetic vaccine particles for durable cytolytic T lymphocyte responses and anti-tumor immunotherapy.

by Petr O Ilyinskii, Grigoriy I Kovalev, Conlin P O'Neil, Christopher J Roy, Alicia M Michaud, Natalia M Drefs, Mikhail A Pechenkin, Fen-Ni Fu, Lloyd P M Johnston, Dmitry A Ovchinnikov, Takashi Kei Kishimoto
Published 2018-01-01